세계의 임상시험 아웃소싱 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2035년)

Clinical Trials Outsourcing Market - Scope of Report

TMR's report on the global clinical trials outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global clinical trials outsourcing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical trials outsourcing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the clinical trials outsourcing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global clinical trials outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global clinical trials outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global clinical trials outsourcing market.

The report delves into the competitive landscape of the global clinical trials outsourcing market. Key players operating in the global clinical trials outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global clinical trials outsourcing market profiled in this report.

Key Questions Answered in Global clinical trials outsourcing market Report:

• What is the sales/revenue generated by clinical trials outsourcing across all regions during the forecast period?
• What are the opportunities in the global clinical trials outsourcing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Clinical Trials Outsourcing Market - Research Objectives and Research Approach

The comprehensive report on the global clinical trials outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global clinical trials outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global clinical trials outsourcing market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Clinical Trials Outsourcing Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Clinical Trials Outsourcing Market Analysis and Forecast, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Key Industry Events
• 5.2. Impact Analysis
• 5.3. PESTEL Analysis
• 5.4. Regulatory Scenario by Key Countries/Regions
• 5.5. PORTER's Five Forces Analysis
• 5.6. Technological Advancements
• 5.7. Fund Raise/Investment Scenario

6. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Service Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Service Type, 2020-2035
  • 6.3.1. Laboratory Services
  • 6.3.2. Bioanalytical Testing Services
  • 6.3.3. Decentralized Clinical Trial Services
  • 6.3.4. Patient Recruitment
  • 6.3.5. Site Identification
  • 6.3.6. Analytical Testing Services
  • 6.3.7. Clinical Trial Supply & Logistic Services
  • 6.3.8. Protocol Designing
  • 6.3.9. Clinical Trial Data Management Services
  • 6.3.10. Medical Device Testing Services
  • 6.3.11. Others
• 6.4. Market Attractiveness Analysis, by Service Type

7. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Therapeutic Area

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Therapeutic Area, 2020-2035
  • 7.3.1. Oncology
  • 7.3.2. Infectious Diseases
  • 7.3.3. Neurology
  • 7.3.4. Metabolic Disorders
  • 7.3.5. Immunology
  • 7.3.6. Cardiology
  • 7.3.7. Genetic Diseases
  • 7.3.8. Women's Health
  • 7.3.9. Others
• 7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Application

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Application, 2020-2035
  • 8.3.1. Small Molecules
  • 8.3.2. Monoclonal Antibodies
  • 8.3.3. Vaccine
  • 8.3.4. Cell & Gene Therapy
  • 8.3.5. Others
• 8.4. Market Attractiveness Analysis, by Application

9. Global Clinical Trials Outsourcing Market Analysis and Forecast, by End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by End-user, 2020-2035
  • 9.3.1. Pharmaceutical and Biotech Companies
  • 9.3.2. Medical Device Manufacturers
• 9.4. Market Attractiveness Analysis, by End-user

10. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Region

• 10.1. Key Findings
• 10.2. Market Value Forecast, by Region, 2020-2035
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America Clinical Trials Outsourcing Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Service Type, 2020-2035
  • 11.2.1. Laboratory Services
  • 11.2.2. Bioanalytical Testing Services
  • 11.2.3. Decentralized Clinical Trial Services
  • 11.2.4. Patient Recruitment
  • 11.2.5. Site Identification
  • 11.2.6. Analytical Testing Services
  • 11.2.7. Clinical Trial Supply & Logistic Services
  • 11.2.8. Protocol Designing
  • 11.2.9. Clinical Trial Data Management Services
  • 11.2.10. Medical Device Testing Services
  • 11.2.11. Others
• 11.3. Market Value Forecast, by Therapeutic Area, 2020-2035
  • 11.3.1. Oncology
  • 11.3.2. Infectious Diseases
  • 11.3.3. Neurology
  • 11.3.4. Metabolic Disorders
  • 11.3.5. Immunology
  • 11.3.6. Cardiology
  • 11.3.7. Genetic Diseases
  • 11.3.8. Women's Health
  • 11.3.9. Others
• 11.4. Market Value Forecast, by Application, 2020-2035
  • 11.4.1. Small Molecules
  • 11.4.2. Monoclonal Antibodies
  • 11.4.3. Vaccine
  • 11.4.4. Cell & Gene Therapy
  • 11.4.5. Others
• 11.5. Market Value Forecast, by End-user, 2020-2035
  • 11.5.1. Pharmaceutical and Biotech Companies
  • 11.5.2. Medical Device Manufacturers
• 11.6. Market Value Forecast, by Country, 2020-2035
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Service Type
  • 11.7.2. By Therapeutic Area
  • 11.7.3. By Application
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Clinical Trials Outsourcing Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Service Type, 2020-2035
  • 12.2.1. Laboratory Services
  • 12.2.2. Bioanalytical Testing Services
  • 12.2.3. Decentralized Clinical Trial Services
  • 12.2.4. Patient Recruitment
  • 12.2.5. Site Identification
  • 12.2.6. Analytical Testing Services
  • 12.2.7. Clinical Trial Supply & Logistic Services
  • 12.2.8. Protocol Designing
  • 12.2.9. Clinical Trial Data Management Services
  • 12.2.10. Medical Device Testing Services
  • 12.2.11. Others
• 12.3. Market Value Forecast, by Therapeutic Area, 2020-2035
  • 12.3.1. Oncology
  • 12.3.2. Infectious Diseases
  • 12.3.3. Neurology
  • 12.3.4. Metabolic Disorders
  • 12.3.5. Immunology
  • 12.3.6. Cardiology
  • 12.3.7. Genetic Diseases
  • 12.3.8. Women's Health
  • 12.3.9. Others
• 12.4. Market Value Forecast, by Application, 2020-2035
  • 12.4.1. Small Molecules
  • 12.4.2. Monoclonal Antibodies
  • 12.4.3. Vaccine
  • 12.4.4. Cell & Gene Therapy
  • 12.4.5. Others
• 12.5. Market Value Forecast, by End-user, 2020-2035
  • 12.5.1. Pharmaceutical and Biotech Companies
  • 12.5.2. Medical Device Manufacturers
• 12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 12.6.1. Germany
  • 12.6.2. UK
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Service Type
  • 12.7.2. By Therapeutic Area
  • 12.7.3. By Application
  • 12.7.4. By End-user
  • 12.7.5. By Country/Sub-region

13. Asia Pacific Clinical Trials Outsourcing Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Service Type, 2020-2035
  • 13.2.1. Laboratory Services
  • 13.2.2. Bioanalytical Testing Services
  • 13.2.3. Decentralized Clinical Trial Services
  • 13.2.4. Patient Recruitment
  • 13.2.5. Site Identification
  • 13.2.6. Analytical Testing Services
  • 13.2.7. Clinical Trial Supply & Logistic Services
  • 13.2.8. Protocol Designing
  • 13.2.9. Clinical Trial Data Management Services
  • 13.2.10. Medical Device Testing Services
  • 13.2.11. Others
• 13.3. Market Value Forecast, by Therapeutic Area, 2020-2035
  • 13.3.1. Oncology
  • 13.3.2. Infectious Diseases
  • 13.3.3. Neurology
  • 13.3.4. Metabolic Disorders
  • 13.3.5. Immunology
  • 13.3.6. Cardiology
  • 13.3.7. Genetic Diseases
  • 13.3.8. Women's Health
  • 13.3.9. Others
• 13.4. Market Value Forecast, by Application, 2020-2035
  • 13.4.1. Small Molecules
  • 13.4.2. Monoclonal Antibodies
  • 13.4.3. Vaccine
  • 13.4.4. Cell & Gene Therapy
  • 13.4.5. Others
• 13.5. Market Value Forecast, by End-user, 2020-2035
  • 13.5.1. Pharmaceutical and Biotech Companies
  • 13.5.2. Medical Device Manufacturers
• 13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Service Type
  • 13.7.2. By Therapeutic Area
  • 13.7.3. By Application
  • 13.7.4. By End-user
  • 13.7.5. By Country/Sub-region

14. Latin America Clinical Trials Outsourcing Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Service Type, 2020-2035
  • 14.2.1. Laboratory Services
  • 14.2.2. Bioanalytical Testing Services
  • 14.2.3. Decentralized Clinical Trial Services
  • 14.2.4. Patient Recruitment
  • 14.2.5. Site Identification
  • 14.2.6. Analytical Testing Services
  • 14.2.7. Clinical Trial Supply & Logistic Services
  • 14.2.8. Protocol Designing
  • 14.2.9. Clinical Trial Data Management Services
  • 14.2.10. Medical Device Testing Services
  • 14.2.11. Others
• 14.3. Market Value Forecast, by Therapeutic Area, 2020-2035
  • 14.3.1. Oncology
  • 14.3.2. Infectious Diseases
  • 14.3.3. Neurology
  • 14.3.4. Metabolic Disorders
  • 14.3.5. Immunology
  • 14.3.6. Cardiology
  • 14.3.7. Genetic Diseases
  • 14.3.8. Women's Health
  • 14.3.9. Others
• 14.4. Market Value Forecast, by Application, 2020-2035
  • 14.4.1. Small Molecules
  • 14.4.2. Monoclonal Antibodies
  • 14.4.3. Vaccine
  • 14.4.4. Cell & Gene Therapy
  • 14.4.5. Others
• 14.5. Market Value Forecast, by End-user, 2020-2035
  • 14.5.1. Pharmaceutical and Biotech Companies
  • 14.5.2. Medical Device Manufacturers
• 14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Service Type
  • 14.7.2. By Therapeutic Area
  • 14.7.3. By Application
  • 14.7.4. By End-user
  • 14.7.5. By Country/Sub-region

15. Middle East & Africa Clinical Trials Outsourcing Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Service Type, 2020-2035
  • 15.2.1. Laboratory Services
  • 15.2.2. Bioanalytical Testing Services
  • 15.2.3. Decentralized Clinical Trial Services
  • 15.2.4. Patient Recruitment
  • 15.2.5. Site Identification
  • 15.2.6. Analytical Testing Services
  • 15.2.7. Clinical Trial Supply & Logistic Services
  • 15.2.8. Protocol Designing
  • 15.2.9. Clinical Trial Data Management Services
  • 15.2.10. Medical Device Testing Services
  • 15.2.11. Others
• 15.3. Market Value Forecast, by Therapeutic Area, 2020-2035
  • 15.3.1. Oncology
  • 15.3.2. Infectious Diseases
  • 15.3.3. Neurology
  • 15.3.4. Metabolic Disorders
  • 15.3.5. Immunology
  • 15.3.6. Cardiology
  • 15.3.7. Genetic Diseases
  • 15.3.8. Women's Health
  • 15.3.9. Others
• 15.4. Market Value Forecast, by Application, 2020-2035
  • 15.4.1. Small Molecules
  • 15.4.2. Monoclonal Antibodies
  • 15.4.3. Vaccine
  • 15.4.4. Cell & Gene Therapy
  • 15.4.5. Others
• 15.5. Market Value Forecast, by End-user, 2020-2035
  • 15.5.1. Pharmaceutical and Biotech Companies
  • 15.5.2. Medical Device Manufacturers
• 15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Service Type
  • 15.7.2. By Therapeutic Area
  • 15.7.3. By Application
  • 15.7.4. By End-user
  • 15.7.5. By Country/Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis, by Company (2024)
• 16.3. Company Profiles
  • 16.3.1. ICON plc
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Product Portfolio
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. IQVIA
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Product Portfolio
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. Thermo Fisher Scientific Inc.
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Product Portfolio
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. SGS Life Sciences
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Product Portfolio
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. Charles River Laboratories
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Product Portfolio
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Parexel
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Product Portfolio
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Syneos Health
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Product Portfolio
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. Medpace
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Product Portfolio
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. LabCorp
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Product Portfolio
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. KCR
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Product Portfolio
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. PRA Health Sciences
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Product Portfolio
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. WuXi AppTec
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Product Portfolio
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments
  • 16.3.13. Pharmaron
    • 16.3.13.1. Company Overview
    • 16.3.13.2. Financial Overview
    • 16.3.13.3. Product Portfolio
    • 16.3.13.4. Business Strategies
    • 16.3.13.5. Recent Developments
  • 16.3.14. Avance Clinical
    • 16.3.14.1. Company Overview
    • 16.3.14.2. Financial Overview
    • 16.3.14.3. Product Portfolio
    • 16.3.14.4. Business Strategies
    • 16.3.14.5. Recent Developments
  • 16.3.15. Pharmaron
    • 16.3.15.1. Company Overview
    • 16.3.15.2. Financial Overview
    • 16.3.15.3. Product Portfolio
    • 16.3.15.4. Business Strategies
    • 16.3.15.5. Recent Developments